![Subhanu Saxena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Subhanu Saxena
Corporate Officer/Principal chez
Gates Foundation Trust
Profil
Mr. Subhanu Saxena is a Managing Partner at New Rhein Healthcare Investors, a Partner at New Rhein Healthcare LLC and a Regional Director at Gates Foundation Trust.
Mr. Saxena was previously employed as a Member-Supervisory Board by Kiadis Pharma NV, a Senior Advisor by Bain Capital Ventures LP, a Regional Director by Bill & Melinda Gates Foundation, a Chairman by American Injectables, Inc., a Head-Global Product Strategy by Novartis Pharma BV, and a Chief Executive Officer and President by Novartis UK Ltd. He also served on the board at Cipla Ltd. He received his graduate degree from the University of Oxford and an MBA from INSEAD.
Postes actifs de Subhanu Saxena
| Sociétés | Poste | Début |
|---|---|---|
Gates Foundation Trust
 Gates Foundation Trust Financial ConglomeratesFinance Foundation | Corporate Officer/Principal | - |
New Rhein Healthcare LLC
 New Rhein Healthcare LLC Investment ManagersFinance Operates private equity investment company | Corporate Officer/Principal | - |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Private Equity Investor | 01/01/2017 |
Anciens postes connus de Subhanu Saxena
| Sociétés | Poste | Fin |
|---|---|---|
Bill & Melinda Gates Foundation
 Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization | Directeur/Membre du Conseil | 01/09/2021 |
Bain Capital Ventures LP
 Bain Capital Ventures LP Investment ManagersFinance Bain Capital Ventures invests in companies located in the United States. The firm targets companies operating across a broad range of industries and sectors with an investment size ranging from USD 1 to 100 million. It provides financing for seed, early and growth stage capital requirements. | Consultant / Advisor | 01/03/2020 |
| CIPLA LIMITED | Directeur Général | 01/09/2016 |
American Injectables, Inc.
 American Injectables, Inc. Pharmaceuticals: MajorHealth Technology Manufactures parenteral drugs | Président | - |
Novartis Pharma BV
 Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a key branch of the Dutch Swiss healthcare company Novartis. The company is based in Amsterdam, the Netherlands. Novartis Pharma focuses on discovering and delivering medicines for therapeutic areas such as cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology, dermatology, and rheumatology. The company supports patients, caregivers, and healthcare professionals with resources including medicine information, clinical research participation guidance, and patient support programs. Novartis Pharma conducts research and development from preclinical studies through four-phase clinical trials, sharing clinical trial results and anonymized patient data to foster scientific progress. The company employs digital tools to enhance trial efficiency and invests in cell and gene therapies for early intervention in chronic diseases. Novartis Pharma collaborates with healthcare providers and patient organizations, offering educational resources and supporting clinical research participation under Dutch law. The company was founded in 1996. The CEO is Vasant Narasimhan. | Corporate Officer/Principal | - |
Formation de Subhanu Saxena
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Finance |
Bain Capital Ventures LP
Bain Capital Ventures LP Investment ManagersFinance Bain Capital Ventures invests in companies located in the United States. The firm targets companies operating across a broad range of industries and sectors with an investment size ranging from USD 1 to 100 million. It provides financing for seed, early and growth stage capital requirements. | Finance |
Cipla Ltd.
 Cipla Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Health Technology |
Novartis Pharma BV
Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a key branch of the Dutch Swiss healthcare company Novartis. The company is based in Amsterdam, the Netherlands. Novartis Pharma focuses on discovering and delivering medicines for therapeutic areas such as cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology, dermatology, and rheumatology. The company supports patients, caregivers, and healthcare professionals with resources including medicine information, clinical research participation guidance, and patient support programs. Novartis Pharma conducts research and development from preclinical studies through four-phase clinical trials, sharing clinical trial results and anonymized patient data to foster scientific progress. The company employs digital tools to enhance trial efficiency and invests in cell and gene therapies for early intervention in chronic diseases. Novartis Pharma collaborates with healthcare providers and patient organizations, offering educational resources and supporting clinical research participation under Dutch law. The company was founded in 1996. The CEO is Vasant Narasimhan. | |
New Rhein Healthcare LLC
New Rhein Healthcare LLC Investment ManagersFinance Operates private equity investment company | Finance |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization | Commercial Services |
American Injectables, Inc.
American Injectables, Inc. Pharmaceuticals: MajorHealth Technology Manufactures parenteral drugs | Health Technology |
